Sunil Healthcare P/E Ratio
Sunil Healthcare (SUNLOC) P/E ratio is 21.7 (Moderate), EPS (TTM) ₹3.91, current price ₹73.49 on NSE vs historical average P/E of 26.1 — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see SUNLOC screener.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
SUNLOC P/E Ratio — Valuation Signal & Historical Context
Sunil Healthcare P/E 21.7 vs historical average 26.1, range 26.1–26.1 — signal: Overvalued.
- Trading at discount to sector average PE of 56.91
Sunil Healthcare P/E Ratio Historical Trend
SUNLOC annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 21.7 vs historical average 26.1. Also explore Sunil Healthcare stock price data download to track price trends across different timeframes.
SUNLOC Historical P/E Ratio — EPS, Year-End Price & Valuation
Sunil Healthcare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 26.1 | 2.78 | ₹72.55 | BSE | High |
SUNLOC vs Healthcare Peers — P/E Ratio Comparison
Sunil Healthcare P/E 21.7 vs Healthcare average 56.91, median 32.06 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |